Jacques Galipeau
#154,268
Most Influential Person Now
Researcher
Jacques Galipeau's AcademicInfluence.com Rankings
Jacques Galipeaubiology Degrees
Biology
#11767
World Rank
#15190
Historical Rank
Cell Biology
#606
World Rank
#619
Historical Rank
Molecular Biology
#1848
World Rank
#1877
Historical Rank
Download Badge
Biology
Why Is Jacques Galipeau Influential?
(Suggest an Edit or Addition)Jacques Galipeau's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. (2018) (949)
- Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. (2012) (582)
- Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. (2005) (543)
- Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. (2009) (408)
- Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. (2000) (398)
- The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? (2013) (386)
- Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. (2013) (354)
- International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. (2016) (347)
- Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. (2019) (329)
- Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. (2006) (319)
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing (2011) (315)
- Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation (2003) (287)
- Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 (2009) (282)
- Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 (2009) (260)
- Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo (2003) (220)
- Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. (2003) (209)
- Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. (2008) (208)
- Retroviral Delivery of Connexin Genes to Human Breast Tumor Cells Inhibits in Vivo Tumor Growth by a Mechanism That Is Independent of Significant Gap Junctional Intercellular Communication* (2002) (207)
- In vivo selection of retrovirally transduced hematopoietic stem cells (1998) (206)
- IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells (2014) (204)
- Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. (1998) (195)
- Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1 (2007) (189)
- Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is Expressed by Mesenchymal Stromal Cells* (2008) (176)
- Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. (2009) (135)
- Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T‐Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing (2016) (134)
- Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. (2013) (134)
- Cell-based therapeutic strategies for multiple sclerosis (2017) (128)
- Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. (2009) (127)
- A granulocyte-macrophage colony–stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties (2009) (123)
- Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. (2018) (119)
- Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. (2007) (118)
- Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. (2015) (117)
- Roles of FGF signaling in stem cell self-renewal, senescence and aging (2011) (113)
- Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo (2014) (112)
- Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. (2011) (111)
- Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy. (2004) (105)
- Challenges for mesenchymal stromal cell therapies (2019) (102)
- Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors (2004) (102)
- Ex Vivo Gene Therapy for Hemophilia A That Enhances Safe Delivery and Sustained In Vivo Factor VIII Expression from Lentivirally Engineered Endothelial Progenitors (2007) (100)
- Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. (2012) (98)
- Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor. (1996) (95)
- Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2 (2014) (93)
- Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. (1999) (93)
- Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. (2009) (86)
- Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy. (2008) (82)
- Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. (2010) (82)
- CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury (2020) (81)
- The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses (2016) (81)
- Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence (2011) (77)
- IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. (2012) (77)
- Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis (2010) (76)
- Neuronal Differentiation and Growth Control of Neuro-2a Cells After Retroviral Gene Delivery of Connexin43* (2000) (76)
- Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion (2018) (75)
- Cooperation of Matrix Metalloproteinases with the RhoA/Rho Kinase and Mitogen‐Activated Protein Kinase Kinase‐1/Extracellular Signal‐Regulated Kinase Signaling Pathways Is Required for the Sphingosine‐1‐Phosphate‐Induced Mobilization of Marrow‐Derived Stromal Cells (2006) (75)
- Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. (2003) (72)
- The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. (2013) (69)
- Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. (2006) (68)
- Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue* (2001) (68)
- Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor (2004) (67)
- Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. (2003) (65)
- The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. (2015) (63)
- Three‐dimensional porous scaffolds at the crossroads of tissue engineering and cell‐based gene therapy (2009) (60)
- Immune plasticity of bone marrow-derived mesenchymal stromal cells. (2007) (59)
- Improved Autograft Survival of Mesenchymal Stromal Cells by Plasminogen Activator Inhibitor 1 Inhibition (2009) (59)
- A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice (2003) (58)
- In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors. (2002) (58)
- A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization. (2016) (57)
- CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. (2008) (56)
- Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy (2004) (53)
- Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy. (1999) (52)
- Death and inflammation following somatic cell transplantation (2011) (50)
- Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. (2005) (50)
- Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis. (2000) (48)
- Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. (2020) (48)
- Evidence for Transcriptional Regulation of the Glucose‐6‐Phosphate Transporter by HIF‐1α: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells (2009) (47)
- Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. (2001) (47)
- Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. (2008) (46)
- Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. (2001) (46)
- Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers. (2019) (46)
- Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy. (2015) (45)
- Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy. (2013) (45)
- The Stem Cell Research Environment: A Patchwork of Patchworks (2009) (43)
- New insights on translational development of mesenchymal stromal cells for suppressor therapy (2012) (42)
- A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. (1997) (41)
- Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation (2016) (41)
- Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease. (2015) (40)
- Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy. (2008) (40)
- Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. (2009) (38)
- Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B. (2011) (38)
- The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells (2003) (37)
- Monocyte Derivatives Promote Angiogenesis and Myocyte Survival in a Model of Myocardial Infarction (2010) (37)
- An Engineered GM-CSF-CCL2 Fusokine Is a Potent Inhibitor of CCR2-Driven Inflammation As Demonstrated in a Murine Model of Inflammatory Arthritis1 (2009) (37)
- Effects of Retroviral‐Mediated MDR1 Expression on Hematopoietic Stem Cell Self‐Renewal and Differentiation in Culture a (1999) (36)
- Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells (2002) (36)
- Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming. (2017) (35)
- A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. (2006) (35)
- Tissue Engineering of Rat Bladder Using Marrow-Derived Mesenchymal Stem Cells and Bladder Acellular Matrix (2014) (34)
- Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells. (2000) (34)
- Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton (2007) (34)
- Mesenchymal stromal cell – derived CCL 2 suppresses plasma cell immunoglobulin production via STAT 3 inactivation and PAX 5 induction (2008) (32)
- MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells (2007) (32)
- Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee. (2020) (32)
- Induction of Cardiac Angiogenesis Requires Killer Cell Lectin-Like Receptor 1 and α4β7 Integrin Expression by NK Cells (2010) (32)
- Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. (2015) (32)
- Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells. (2007) (31)
- Connexin Over-Expression Differentially Suppresses Glioma Growth and Contributes to the Bystander Effect Following HSV-Thymidine Kinase Gene Therapy (2006) (31)
- Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia. (2008) (30)
- Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. (2004) (30)
- The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies. (2012) (29)
- Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense. (2001) (29)
- Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity (2021) (29)
- Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies (2013) (29)
- Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells (1998) (28)
- TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect (2008) (28)
- Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients (2015) (28)
- Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells (2018) (26)
- Concerns arising from MSC retrieval from cryostorage and effect on immune suppressive function and pharmaceutical usage in clinical trials (2013) (26)
- Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential (2020) (26)
- Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. (2011) (26)
- Novel TGF-β Antagonist Inhibits Tumor Growth and Angiogenesis by Inducing IL-2 Receptor-Driven STAT1 Activation (2011) (26)
- Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. (2021) (25)
- Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways (2007) (25)
- Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. (2009) (24)
- A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo. (2010) (23)
- The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation. (2009) (23)
- Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies (2008) (22)
- MSCs: science and trials (2013) (22)
- GM-CSF–Based Fusion Cytokines as Ligands for Immune Modulation (2011) (22)
- Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs (2015) (22)
- Adoptive transfer of mesenchymal stromal cells accelerates intestinal epithelium recovery of irradiated mice in an interleukin-6-dependent manner. (2012) (22)
- The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells (2017) (22)
- Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells (2018) (21)
- A Fusion Cytokine Coupling GMCSF to IL9 Induces Heterologous Receptor Clustering and STAT1 Hyperactivation through JAK2 Promiscuity (2013) (21)
- Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review. (2009) (21)
- The carboxylation efficiency of the vitamin K‐dependent clotting factors: studies with factor IX (2008) (21)
- Development and Function of Innate Polyclonal TCRαβ+ CD8+ Thymocytes (2011) (21)
- Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination (2020) (20)
- A MCP1 fusokine with CCR2-specific tumoricidal activity (2011) (20)
- Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. (2010) (19)
- Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response. (2014) (18)
- Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine1 (2009) (18)
- A Dendritic Cell Population Generated by a Fusion of GM-CSF and IL-21 Induces Tumor-Antigen–Specific Immunity (2010) (18)
- Stem cell research ethics: consensus statement on emerging issues. (2007) (18)
- Mesenchymal Stem Cells and Tissue Repair (2012) (17)
- Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation. (2009) (17)
- Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy (2020) (17)
- BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth (2016) (17)
- Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors (2006) (17)
- Potency Analysis of Mesenchymal Stromal Cells Using a Phospho‐STAT Matrix Loop Analytical Approach (2019) (16)
- Response to Nature commentary "Clear up this stem-cell mess". (2019) (15)
- GMCSF‐Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer (2011) (15)
- Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease (2021) (15)
- B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunity. (2012) (14)
- Concise Review: Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders (2015) (14)
- Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality. (2017) (13)
- A Novel and Simplified Method of Culture of Human Blood-Derived Early Endothelial Progenitor Cells for the Treatment of Ischemic Vascular Disease (2011) (13)
- Maltose-Binding Protein Fusion Allows for High Level Bacterial Expression and Purification of Bioactive Mammalian Cytokine Derivatives (2014) (13)
- Perspectives of the International Society of Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi). (2019) (13)
- Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells (2019) (13)
- Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein. (2016) (13)
- International stem cell environments: a world of difference (2009) (13)
- Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1. (2015) (12)
- Reprogramming of B cells into regulatory cells with engineered fusokines. (2012) (11)
- GIFT4 fusokine converts leukemic B cells into immune helper cells (2016) (10)
- Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience. (2017) (9)
- Innate immune responses of equine monocytes cultured in equine platelet lysate. (2018) (9)
- Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation (2015) (9)
- [The use of mesenchymal stromal cells in oncology and cell therapy]. (2006) (9)
- The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4. (2002) (9)
- Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model (2018) (9)
- From Single Nucleotide Polymorphisms to Constant Immunosuppression: Mesenchymal Stem Cell Therapy for Autoimmune Diseases (2013) (9)
- Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th1 (2009) (9)
- Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization. (2012) (9)
- L’utilisation des cellules souches mésenchymateuses en oncologie et thérapie cellulaire (2006) (8)
- Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice (2013) (8)
- Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells. (2021) (8)
- A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseases. (2010) (8)
- Coding region-specific destabilization of mRNA transcripts attenuates expression from retroviral vectors containing class 1 aldehyde dehydrogenase cDNAs. (1997) (8)
- FIST, a sword and shield fusokine for cancer immunotherapy (2012) (7)
- Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients (2018) (7)
- Mesenchymal stromal cells for GVHD: A Trilogy. (2020) (7)
- A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells (2006) (7)
- Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft Versus Host Disease (2021) (6)
- Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. (2017) (6)
- B cells for cancer immunotherapy (2014) (6)
- Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage? (2009) (6)
- Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA (2015) (6)
- Reply: “Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon‐γ Prelicensing Is Context Dependent” (2017) (5)
- Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products. (2022) (5)
- Aryl hydrocarbon receptor in mesenchymal stromal cells: new frontiers in AhR biology (2020) (5)
- Galectin 3‐binding protein is a potential contaminant of recombinantly produced factor IX (2007) (5)
- Green fluorescent protein in retroviral vector constructs as marker and reporter of gene expression for cell and gene therapy applications. (2002) (5)
- Disruption of NF-κB Signaling and Chemokine Gene Activation by Retroviral Mediated Expression of IKKγ/NEMO Mutants (2001) (5)
- Integrin Expression by NK Cells Killer Cell Lectin-Like Receptor 1 and Induction of Cardiac Angiogenesis Requires (2010) (4)
- Allogeneic Versus Autologous Mesenchymal Stromal Cells and Donor-to-Donor Variability (2017) (4)
- Catalyzing umbilical cord blood research in Canada: a survey of current needs and practices of principal investigators. (2009) (4)
- A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells. (2001) (4)
- A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States (2016) (4)
- A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo. (2010) (3)
- Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells. (2021) (3)
- Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells (2018) (3)
- A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency (2015) (3)
- Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients. (2021) (3)
- X-linked genes exhibit miR6891-5p-regulated skewing in Sjögren’s syndrome (2022) (3)
- Minor salivary gland mesenchymal stromal cells derived from patients with Sjӧgren's syndrome deploy intact immune plasticity. (2020) (3)
- Peripheral Regulatory B Cell Phenotype in Multiple Sclerosis Patients (2012) (2)
- C-39: The impact of cryopreservation on fitness of cell therapy products in human clinical trials – the MSC paradigm (2014) (2)
- Une cytokine chimérique au secours des maladies auto-immunes (2010) (2)
- Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization. (2012) (2)
- Advances in Brief In Vivo Interferon Regulatory Factor 3 Tumor Suppressor Activity in B 16 Melanoma Tumors 1 (2002) (2)
- An ISCT MSC Committee Editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for COVID-19: Time for a global registry (2022) (2)
- IDO Expression In Human Mesenchymal Stromal Cells Mediates T Cell Suppression and Leads to Monocyte Differentiation Into IL-10 Secreting Immunosuppressive CD206+ M2 Macrophages (2010) (2)
- Washed equine platelet extract (WEPLEX) as an anti-inflammatory biologic pharmaceutical. (2020) (2)
- GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration. (2017) (2)
- GIFT15 fusokine to foil immunity's follies. (2009) (2)
- Induction of Increased Levels of Matrix Metalloproteinase-2 (MMP-2) and -9 in Human Breast Cancer Cell Lines by Activation of GM-CSF Receptor Bc via C-Fos-ERK 1/2 Signaling (2017) (1)
- 918. Autologous canine bone marrow stromal cells retrovirally engineered with the canine EPO gene and implanted in vivo in a collagen matrix produce and release systemically functional EPO over a prolonged period (2004) (1)
- Image-Guided Transarterial Directed Delivery of Human Mesenchymal Stem Cells for Targeted Gastrointestinal Therapies in a Swine Model. (2019) (1)
- Defining mesenchymal stromal cells responsiveness to IFNγ as a surrogate measure of suppressive potency (2014) (1)
- MSC immunomodulation and aryl hydrocarbons receptor activation by tryptophan catabolites (2015) (1)
- CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling (2022) (1)
- Tryptophan Catabolites Directly Modulate the Immunosuppressive Effects of MSCs Via Activation of the Endogenous Aryl Hydrocarbon Receptor (2014) (1)
- Ruxolitinib Inhibits IFNγ-stimulated Sjögren's Salivary Gland MSC HLA-DR Expression and Chemokine-Dependent T-cell Migration. (2022) (1)
- Genomic, Proteomic and Functional Screens Identify PAI-1 as an Important Factor Influencing Mesenchymal Stromal Cell Survival Post-Transplantation In Vivo . (2007) (1)
- Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants. (2001) (1)
- Chapter 99 – Mesenchymal Stromal Cells (2018) (1)
- A GMCSF/Interleukin-15 Fusokine Leads to the Generation of a Novel Type of CD2/MHCII Immune Regulatory Cell with Potent Immune Suppressive Properties as Demonstrated in the EAE Mouse Model of Multiple Sclerosis. (2007) (1)
- 174 BONE MARROW MESENCHYMAL STROMAL CELL THERAPY FOR EXTERNAL URETHRAL SPHINCTER RESTORATION IN A RAT MODEL OF STRESS URINARY INCONTINENCE (2011) (1)
- A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States (2016) (1)
- 972. Gene-Modified Human Glioma Cells Producing Soluble Human Plasminogen Kringle 5 Peptide Suppress Brain Tumor Progression (2004) (1)
- Mesenchymal Stromal Cells: An Emerging Cell-Based Pharmaceutical (2011) (1)
- Development and Function of Innate Polyclonal TCRab CD8 Thymocytes (2011) (1)
- Bone marrow mesenchymal stromal cells from patients with acute and chronic gvhd deploy normal phenotype, differentiation plasticity and immune-suppressive activity (2015) (1)
- Mesenchymal Stromal Cells Expressing ErbB-2/ neu Elicit Protective Antibreast Tumor Immunity In vivo , Which Is Paradoxically Suppressed by IFN- γ and Tumor Necrosis Factor- α Priming (2010) (1)
- 911. MHC class I and II mismatched marrow stromal cells from C57Bl/6 mice are immune rejected by recipient Balb/c mice (2004) (1)
- Mesenchymal stromal cells for the treatment of autoimmune diseases (2016) (1)
- Compositions, utilisations et préparation de lysats de plaquettes (2012) (0)
- Combination immunotherapy with anti-CD38 and ex vivo stimulated aß t-cell depleted pbmcs for multiple myeloma (2021) (0)
- 925 BONE MARROW MESENCHYMAL STROMAL CELL THERAPY FOR EXTERNAL URETHRAL SPHINCTER RESTORATION IN A RAT MODEL OF STRESS URINARY INCONTINENCE (2011) (0)
- In vivo administration of a novel synthetic GMCSF and IL7 fusion cytokine (GIFT7) leads to transient thymic hyperplasia by driving double-negative (DN), single-positive CD8 (SPCD8) and gamma-delta ({gamma}{delta}) thymocyte proliferation (2012) (0)
- Soluble human plasminogen kringle 5 domain acts as a 2-pronged anti-cancer agent inhibiting both endothelial cells and tumor-associated macrophages (2005) (0)
- Adoptive Cell Therapy With Autologous Induced Regulatory B Cells In Experimental Autoimmune Encephalomyelitis (2015) (0)
- Abstract 18310: Therapeutic Use of Encapsulated Genetically Engineered Mesenchymal Stem Cells for Vascular Regeneration (2013) (0)
- Pseudotyped retrovectors for tumor-specific delivery of toxic suicide genes. (2001) (0)
- CXCR4 Synergistically Activates FLT3 Receptor and Regulates Mobilization of Innate Immune and Stem Progenitor Cells Post-Myocardial Infarction (2007) (0)
- 91 - Intact phenotype and functionality of bone marrow derived mesenchymal stromal cells from individuals with sickle cell disease (2017) (0)
- blood flow in a chronic limb ischemia model Therapeutic angiogenesis using autologous bone marrow stromal cells: improved (2013) (0)
- 1069 Bone marrow mesenchymal stromal cell therapy for restoration of bladder wall defects (2012) (0)
- Mesenchymal Stem Cells: From Bench to Bedside and Back (2018) (0)
- 1 MT 1-MMP DOWNREGULATES THE GLUCOSE-6-PHOSPHATE TRANSPORTER EXPRESSION IN MARROW STROMAL CELLS : A MOLECULAR LINK BETWEEN proMMP-2 ACTIVATION , CHEMOTAXIS AND CELL SURVIVAL (2006) (0)
- Fusokine GIFT4 triggers novel B Cell function on hematopoietic stem cells (2015) (0)
- A novel synthetic GMCSF and IL7 fusion cytokine (GIFT7) overcomes T cell exhaustion leading to central memory T cell formation and promoting peripheral T cell expansion in a PD1-low state (165.8) (2012) (0)
- The Fusokine FIST15 Enhances Anti-Tumor Immunity Against Murine Osteosarcoma and Prevents Gvhd after Bone Marrow Transplant (2020) (0)
- Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion (2018) (0)
- Next steps for MSC innovation (2023) (0)
- Regulation of TLR Expression and Activation in Human Mesenchymal Stromal Cells by IFN-a, IFN-g and TNF-a. (2007) (0)
- Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion (2019) (0)
- Erythropoietin (Epo) Secreting Mesenchymal Stromal Cells and Autocrine Signalling Via the Epo Receptor. A Novel, Cell-Based Paracrine Epo Delivery System for Cardiovascular Therapy. (2007) (0)
- Mesenchymal stromal cell immunomodulation and aryl hydrocarbon receptor activation by tryptophan catabolites (IRM9P.462) (2015) (0)
- Luc Sensébé, champion of MSCs, dies. (2020) (0)
- Marrow mesenchymal stromal cells derived from subjects with Crohn’s Disease deploy IDO mediated immune suppression, independent of autophagy process (2015) (0)
- Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells (2018) (0)
- 200 BONE MARROW MESENCHYMAL STROMAL CELL THERAPY FOR RESTORATION OF BLADDER WALL DEFECTS (2012) (0)
- Bone marrow derived mesenchymal stromal cells differ from hepatic stellate cells and attenuate liver fibrosis (2015) (0)
- immunoglobulin production via STAT3 inactivation and PAX5 induction derived CCL2 suppresses plasma cell - Mesenchymal stromal cell (2013) (0)
- Corrigendum to "Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression" [American Journal of Transplantation (2022) 2571-2585]. (2023) (0)
- 312. Human Plasminogen Kringle 5-Engineered Murine Mammary Cancer Cells Arrest Tumor Growth and Promote Long-Term Survival (2005) (0)
- A GMP process for the manufacture and quality control release testing of metabolically fit autologous IFNy-stimulated mscs for xerostomia (TC-MSC(M)-IFNy (2021) (0)
- [A chimeric cytokine to help autoimmune diseases]. (2010) (0)
- IFNγ Licensed Human Bone Marrow Derived Mesenchymal Stromal Cells Inhibit T Cell Cytokine Production by a Mechanism Independent of Indoleamine 2 3-Dioxygenase (IDO) Activity (2012) (0)
- for Immune Modulation Based Fusion Cytokines as Ligands - GM-CSF (2013) (0)
- Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer 1 (1999) (0)
- Islet allografts expressing a PD‐L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression (2022) (0)
- 427 COMPARING DIFFERENT DECELLULARIZATION PROTOCOLS OF ANIMALS' BLADDERS FOR MESENCHYMAL STEM CELL-BASED TISSUE ENGINEERING (2011) (0)
- immunoglobulin production via STAT3 inactivation and PAX5 induction Mesenchymal stromal cell derived CCL2 suppresses plasma cell (2013) (0)
- Abstract 3152: IFN-gamma stimulated cryopreserved mesenchymal stromal cells for treatment of radiation induced xerostomia (2022) (0)
- A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation (2022) (0)
- A Novel Synthetic GMCSF and IL7 Fusion Cytokine (GIFT7) Leads to T Cell Neogenesis by Reversing Age-Related Thymic Atrophy and Overcoming PD-1-Assocaited CD8 Exhaustion (2012) (0)
- BONE MARROW MESENCHYMAL STROMAL CELLS DISPLAY A SMOOTH MUSCLE PHENOTYPE WHICH IS ENHANCED BY TGFβ1: POTENTIAL USE TO TREAT SPHINCTERIC INCONTINENCE AND BLADDER WALL DEFECT (2009) (0)
- A STAT5-Smad3 Dyad Regulates Adipogenic Plasticity and Immune Regulatory Properties of Visceral Mesenchymal Stromal Cells Under Chronic Inflammation (2021) (0)
- Independent mechanisms underlie the protective effect of dietary polyunsaturated fatty acid supplementation and Gαz deficiency on the early type 1 diabetes phenotype of Non-obese diabetic (NOD) mice (2021) (0)
- IFN-g-Stimulated Mesenchymal Stromal Cells Acquire the Ability To Cross-Present Exogenous Soluble Antigens and Lead to an Effective Immune Response. (2007) (0)
- A Novel Dendritic Cell Population Generated by Fusing Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-21 Induces Tumor-Antigen Specific Immunity (2010) (0)
- 57 Neo-organoid of mesenchymal stem cells engineered to secrete a CC-chemokine chimeric fusokine reverses EAE (2008) (0)
- Anti-adipogenic effects of interferon-gamma is mediated by a stat5-smad3 dyad in visceral adipose mesenchymal stromal cells (2021) (0)
- DC-based anti-tumor immunotherapy (WS-071) (2010) (0)
- A GMCSF & IL15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signalling throughthe IL15 receptor complex Running title : GIFT15 Fusokine with Immunosuppressive Properties (2006) (0)
- WS-071 DC-based anti-tumor immunotherapy (2010) (0)
- Human Mesenchymal Stromal Cells Licensed − γ Effector Function by IFN-IDO-Independent Suppression of T Cell (2014) (0)
- 288 Chimeric fusokines borne of the marriage of the TGFβ receptor II ectodomain and pro-inflammatory cytokines IL2 and GMCSF for breast cancer immunotherapy (2008) (0)
- Purified Peritoneal Macrophages Do Not Promote Angiogenesis In Vivo . (2005) (0)
- Mesenchymal Stromal Cell Derived CCL2 Suppresses Plasma Cell Immunoglobulin Production via STAT3 Inactivation and PAX5 Induction Running title: Plasmocyte Inhibition by Stromal Cells (2008) (0)
- Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy (2020) (0)
- Interleukin-2 Enhances Angiogenesis and Preserves Cardiac Function Following Myocardial infarction (2010) (0)
- Transcriptome and Secretome Based Assay Matrix to Define Mesenchymal Stromal Cell Immune Potency (2016) (0)
- Gene Therapy for the Treatment of Cancer (2004) (0)
- Periostin Is a Previously Uncharacterised Vitamin K Dependent γ-Carboxyglutamic Acid (Gla) Containing Protein Expressed by Marrow-Derived Mesenchymal Stromal Cells. (2007) (0)
- Bone Marrow Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Normal Phenotype and Immunomodulatory Capacity (2016) (0)
- Effect of B cell purification and cryopreservation on the production of human regulatory B cells for translational use (2015) (0)
- Adoptive transfer of regulatory IL-10 + B cells leads to decrease of myeloid derived macrophages in the central nervous system of a murine model of amyotrophic lateral sclerosis (2018) (0)
- Replicative senescence associated impairment of immunosuppressive properties of Mesenchymal stromal cells (2015) (0)
- Matrix molecular genetic and secretome responses to immune responders distinguishes the immunobiology of MSCs originating from liver and bone marrow (2018) (0)
- An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry (2022) (0)
- Activation of NK and CD8+ T-Cells with a Novel IL-15 and TGF-Beta Receptor Fusion Protein Confers Anti-Tumor Immunity (2015) (0)
- Abstract 2845: Synthetic fusion cytokine, GIFT4, transduced autologous peritoneal immune cells - a novel cell therapy for the treatment of ovarian cancer (2022) (0)
- Skewed escape from X-inactivation underlies female bias in Sjögren’s syndrome (2021) (0)
- Fusokine-augmented B cells for cancer immunotherapy (2015) (0)
- A Novel Synthetic GMCSF and MCP3 Fusion Cytokine Induces IL10-Producing B Cells with Immune Modulatory Properties on Antigen Presentation and Th17 Development (2010) (0)
- Targeting endogenous mesenchymal stromal cell response to interferon γ in sjögren’s syndrome (2021) (0)
- Role of Virus-Speci fi c T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients (2021) (0)
- Immune-Modulatory Effects of Mesenchymal Stromal Cell Infusions for the Treatment of Factor VIII Inhibitor in Hemophilia A. (2009) (0)
- Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment (2022) (0)
- Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation (2015) (0)
- Inducible B effector cells (iBECs) for cancer immunotherapy (46.4) (2012) (0)
- Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease (2022) (0)
- IMMU-29. PERIPHERAL VACCINATION WITH GIFT-7 SECRETING TUMOR CELLS AUGMENTS AGE RELATED THYMIC DECLINE AND IMPROVES SURVIVAL ACROSS MULTIPLE GLIOBLASTOMA MOUSE MODELS (2022) (0)
- Mesenchymal Stromal Cells as Effective Tumor Antigen‐Presenting Cells in Cancer Therapeutics (2013) (0)
- 349. GM-CSF / IL-2 Fusion Transgene is More Potent than GM-CSF and IL-2 in Combination and is Dependent upon CD8 and NK Cells for Antitumor Effect (2004) (0)
- 334. Treatment of Anemia in Mice with Chronic Renal Failure Utilizing Erythropoietin-Secreting Genetically-Engineered Murine Bone Marrow Stromal Cells (2005) (0)
- Cryobanked MSCs Have a Markedly Increased Susceptibility to T-cell Mediated Contact Cytolysis in Vitro Immediately Post Thaw and Shortened in Vivo Persistence Relative to Physiologically Fit Culture-rescued MSCs (2016) (0)
- Influence of shear stress on transcatheter stem cell delivery quality (2017) (0)
- Bone marrow-derived mesenchymal stromal cells (MSCs) as efficient in vivo cellular vehicles for plasma soluble protein delivery (2008) (0)
- Synergistic activation of JAK/STAT and NF-kB pathways by GMCSF/IL2 fusion protein induces robust NK cell proliferation and activation (2008) (0)
- Manufacturing of autologous BM-MSCs for the treatment of crohn's disease: validation a from Phase I clinical trial (NCT01659762) (2015) (0)
- COMPARATIVE DECELLULARIZATION PROTOCOLS OF RAT, RABBIT AND PORCINE BLADDERS FOR MESENCHYMAL STEM CELL-BASED TISSUE ENGINEERING (2011) (0)
- Differential Molecular Genetic Responses and Secretome of Bone Marrow Derived Mesenchymal Stromal Cells From Hepatic Stellate Cells Define Anti-Fibrotic Effect in the Liver (2016) (0)
- Model of Inflammatory Arthritis Inflammation As Demonstrated in a Murine Potent Inhibitor of CCR2-Driven An Engineered GM-CSF-CCL2 Fusokine Is a (2009) (0)
- Safety and Efficacy of Autologous and Metabolically Fit Bone Marrow Mesenchymal Stromal Cells (BM-MSC) in Medically Refractory Crohn's Disease (CD) (2016) (0)
- Mesenchymal Stromal Cells Genetically Engineered To Overexpress Insulin-Like Growth Factor-1 Provide Paracrine Support for Cell-Based Erythropoietin Therapy of Chronic Renal Failure-Induced Anemia. (2007) (0)
- GIFT4-augmented B cells for melanoma immunotherapy (2014) (0)
- In vivo administration of a novel synthetic GMCSF and IL7 fusion cytokine (GIFT7) leads to transient thymic hyperplasia by driving double-negative (DN), single-positive CD8 (SPCD8) and gamma-delta (γδ) thymocyte proliferation (165.7) (2012) (0)
- A Pilot Study to Assess the Salivary Gland Regenerative Potential of Bone Marrow Mesenchymal Stromal Cells from Treated Head and Neck Cancer Patients (2021) (0)
- 146 A GMCSF and CCL2 fusion chimera induces apoptosis in CCR2 expressing lymphomyeloid cells and promotes xenotolerance (2008) (0)
- Marrow-Derived Mesenchymal Stromal Cells Can Block an Antigen-Driven Humoral Response by Suppressing Plasma Cell Activity Via Production of CCL2. (2007) (0)
- Mesenchymal Stromal Cells Accelerate Hematopoietic Reconstitution and Mediate An IL6-Dependent Regeneration of the Intestinal Epithelium of Lethally Irradiated Mice. (2010) (0)
- Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion (2019) (0)
- TITLE : Genetically Engineered Autologous Cells for Antiangiogenic Therapy of Breast Cancer (0)
- Ex Vivo Gene Trasfer for Hemophilia A That Enhances Safety and Results in Sustained In Vivo Factor VIII Expression from Lentivirally-Engineered Endothelial Progenitors. (2006) (0)
- GM-CSF and IL-4 Derived Fusion Cytokine Reprograms Leukemic B-Cells to Anti-CLL Effectors (2012) (0)
- Galectin-3 Binding Protein Contaminates the Purification of Recombinant Factor IX. (2006) (0)
- Transduction of unopposed STAT-3 signaling in B-cells by a GM-CSF and IL-15 fusion protein results in the formation of immunosuppressive regulatory B-cells (2015) (0)
- Modeling the blood-nerve barrier using human pluripotent stem cell – derived Schwann – like cells and endothelial cells (2019) (0)
- Novel TGF-β antagonist and IL-15 fusion protein enhances formation of memory CD8+ T-cells and prevents the formation of regulatory CD4+ T-cells (2015) (0)
- Mesenchymal Stromal Cells Engineered To Express IL-12 for Breast Cancer Cellular Immunotherapy. (2007) (0)
- Abstract A11: GIFT4-reprogrammed leukemic B cells for CLL immunotherapy. (2015) (0)
- Molecular and Endocrine Mechanisms Underlying the Stem Cell Theory of Aging (2014) (0)
- 268. Primary Mouse Marrow Stromal Cells Behave as Antigen-Presenting Cells in Syngeneic Immune Responses (2005) (0)
- Immunostimulatory Properties of the Human Ortholog of the GMCSF/IL2 Fusion Protein for Cell Based Therapy. (2007) (0)
- Brief Report A Novel Parasite-Derived Suicide Gene for Cancer Gene Therapy with Specificity for Lung Cancer Cells (2001) (0)
- Autologous mesenchymal stromal cells to support allogeneic hematopoietic stem cell engraftment in sickle cell disease (2015) (0)
- Abstract B24: A multicellular, microfluidic model of the human bone marrow niche in metastatic cancers (2020) (0)
- Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential TaggedEnd (0)
- Mesenchymal Stromal Cells Gene-Enhanced To Express Human Factor IX and Their In Vivo Use for Correction of Hemophilia B Phenotype in R333Q Mice. (2007) (0)
- Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model (2018) (0)
- Pancreatic stellate cells maintain endocrine islet viability and function in vitro in a laminin-dependent mechanism (2021) (0)
- Interferon-gamma prelicensed allogeneic bone marrow MSCS do not mitigate graft vs host disease in the animal model of major mismatched bone marrow transplantation (2021) (0)
- Mesenchymal Stem Cells for Vascular Target Discovery in Breast Cancer-Associated Angiogenesis (2004) (0)
- A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation (2022) (0)
- Pancreatic stellate cells prolong porcine islet survival and preserve function in-vitro (2018) (0)
- Abstract 1793: 5-Fluorouracil chemotherapy acts synergistically with adoptive dendritic cell immunotherapy to induce durable anti-tumor responsesin vivo (2011) (0)
- Ex Vivo Gene Therapy for Haemophilia A: FVIII-Overexpressing Mesenchymal Stromal Cells Fail To Produce Sustained Therapeutic Levels of Circulating FVIII In Vivo. (2006) (0)
- A GM-CSF and IL-4 Fusion Cytokine Triggers Conversion of B-Cells to Tumoricidal Effectors (2012) (0)
- Thymus-derived innate CD8+CD44hi T cells display features of antigen-experienced T cells with bystander helper properties (153.43) (2011) (0)
- Genetically Engineered Autologous Cells for Antiangiogenic Therapy of Breast Cancer (2004) (0)
- Protéines de fusion et procédés de modulation de réponse immune (2007) (0)
- Les feux de la rampe (1996) (0)
- Conjugués de gm-csf et d'il-4, compositions et procédés associés (2013) (0)
- Conjugués de gm-csf et d'il-7, compositions en contenant et méthodes associées (2012) (0)
- Nouveau transgene de fusion chimerique synthetique a utilisations immunotherapeutiques (2002) (0)
- Cellules de stroma cultivees et leurs utilisations (2002) (0)
- GIFT4 fusokine converts leukemic B cells into immune helper cells (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jacques Galipeau?
Jacques Galipeau is affiliated with the following schools:
